Daewoong Pharma (069620) — Long-term Investment Intensity
Daewoong Pharma (069620) has a Long-term Investment Intensity of 2.6% as of December 2019. Long-term investments of ₩32.14 Billion represent 2.6% of total assets of ₩1.25 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 069620 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daewoong Pharma Long-term Investment Intensity (2013–2019)
This chart shows how Daewoong Pharma's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 2.6%, reflecting long-term investments of ₩32.14 Billion against total assets of ₩1.25 Trillion KRW. For the complete balance sheet picture, see total assets of Daewoong Pharma.
Annual Long-term Investment Intensity for Daewoong Pharma (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Daewoong Pharma from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 069620 liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 2.6% | ₩32.14 Billion | ₩1.25 Trillion | ▲ +1.1 pp |
| 2018 | 1.5% | ₩18.12 Billion | ₩1.21 Trillion | ▲ +0.8 pp |
| 2017 | 0.7% | ₩8.05 Billion | ₩1.21 Trillion | ▼ -0.1 pp |
| 2016 | 0.8% | ₩8.67 Billion | ₩1.14 Trillion | ▼ -0.3 pp |
| 2015 | 1.1% | ₩10.26 Billion | ₩944.53 Billion | ▼ -0.7 pp |
| 2014 | 1.8% | ₩12.25 Billion | ₩694.26 Billion | ▼ -1.1 pp |
| 2013 | 2.9% | ₩16.74 Billion | ₩579.01 Billion | — |